04/02/2024
2:24 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
2:29 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
4:24 PM | Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2024
4:27 PM | Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:03 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:00 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
3:30 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/22/2024
3:32 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:34 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
2:13 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:16 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:18 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:20 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:11 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
1:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G | |
01/19/2024
3:32 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:34 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:20 PM | Voyager Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/17/2024
2:21 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
2:33 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:49 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
4:20 PM | Voyager Therapeutics (Filer)
| Form 424B5 | |
01/02/2024
6:05 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:04 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:41 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:24 PM | Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:44 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
12:57 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2023
3:18 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:00 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:15 AM | Voyager Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023
3:46 PM | Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2023
3:46 PM | Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:42 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
7:04 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
10:45 AM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
3:32 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
9:31 AM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
3:37 PM | Colon Grace (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:38 PM | Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
AI finds its first serious application (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
06/07/2023
3:39 PM | Onyia Jude (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:40 PM | Vitale Nancy (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:40 PM | MACKEY CATHERINE J (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:41 PM | PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:30 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
3:34 PM | Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:35 PM | SCANGOS GEORGE A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:36 PM | GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
4:15 PM | SCANGOS GEORGE A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
6:30 AM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
05/09/2023
6:16 AM | Voyager Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:03 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
6:05 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
3:30 PM | Voyager Therapeutics (Filer)
| Form ARS | |
04/27/2023
7:00 AM | Voyager Therapeutics (Filer)
| Form DEF 14A | |
04/27/2023
7:01 AM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
